Yunkang Group Limited (02325.HK) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 5Aug 10Aug 13Aug 18Aug 21Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−7.0x

Market Cap

HKD 298.53M

MomentumView details →

1D Return

−3.77%

YTD Return

−48.48%

RSI (14)

23.9

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−7.0x

Market Cap

HKD 298.53M

RSI (14)

23.9

MomentumView details →

1D Return

−3.77%

YTD Return

−48.48%

ProfitabilityView details →

Gross Margin

30.40%

Net Margin

0.49%

EBITDA Margin

17.68%

ROE (TTM)

0.25%

ROA (TTM)

0.11%

Asset Turnover

0.22x

GrowthView details →

Revenue YoY

−15.53%

EPS YoY

+100.03%

FCF YoY

−100.00%

Revenue CAGR 3Y

−45.70%

EPS CAGR 3Y

−80.36%

EBITDA YoY

+114.92%

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.60x

Current Ratio

1.59x

Quick Ratio

1.58x

Div Yield

—

Div Rate

—

Div Growth 1Y

−90.91%

Financials snapshotView financials →

Revenue (TTM)

601.39M

Net Income (TTM)

2.92M

Op. CF (TTM)

0.00

Next earningsMar 31, 2027 →

Latest newsMore news →

No recent news for 02325.HK.

Similar companies

Myriad Genetics, Inc.MYGN Biodesix, Inc.BDSX King International Investment Limited00928.HK Neuronetics, Inc.STIM Biosino Bio-Technology & Science Inc.08247.HK Prenetics Global LimitedPRE Find similar companies →

Latest newsMore news →

No recent news for 02325.HK.